|
DNLI Denali Therapeutics Inc 1714899 |
| Balance Sheet |
|
Current Assets
|
$753,927,000.00 |
|
Assets
|
$1,157,955,000.00 |
|
Current Liabilities
|
$90,083,000.00 |
|
Liabilities
|
$322,777,000.00 |
|
Equity
|
$835,178,000.00 |
|
Shares Out
|
159755526.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-228,206,000.00 |
|
Investing Cash Flow
|
$-9,618,000.00 |
| Market Analysis |
Market Cap
|
$3,985,900,373.70 |
|
Price
|
$24.95 |
|
BVPS
|
5.23 |
|
PB
|
4.77 |
|
EPS
|
-0.68 |
|
PS
|
276.49 |
|
FCF
|
$-231,477,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:26 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:17 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.73 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.69 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.72 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.74 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DNLI documents filed with the SEC.
DNLI Filings
Clear
